Inequality in Drug Utilization among Chronic Myeloid Leukaemia Patients in Malaysia: A Cost-Utility Analysis

BACKGROUND: The burden of chronic myeloid leukaemia (CML) is increasing due to longer patient survival, better life expectancy of the general population, and increasing drug prices. Funding is one of the main concerns in the choice of CML medication used worldwide; thus, patient assistance programme...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Puteh, Sharifa Ezat Wan, Selamat, Ellyana Mohamad, Aizuddin, Azimatun Noor, Tumian, Nor Rafeah, Sathar, Jameela
Aineistotyyppi: Online Artikkeli Teksti
Kieli:English
Julkaistu: West Asia Organization for Cancer Prevention 2022
Aiheet:
Research Article
Linkit:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971449/
https://www.ncbi.nlm.nih.gov/pubmed/36580008
http://dx.doi.org/10.31557/APJCP.2022.23.12.4253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971449/
https://www.ncbi.nlm.nih.gov/pubmed/36580008
http://dx.doi.org/10.31557/APJCP.2022.23.12.4253

Samankaltaisia teoksia